Bu çalışmada, Kangal köpeklerinde penis ereksiyonu, sperma hacmi ve özellikleri üzerine sildenafilin etkisi çalışıldı. Yaşları 3 ila 6 arasında değişen toplam 5 baş fertilitesi bilinen Kangal ırkı köpek kullanıldı. Her bir uygulamada sperma alma işleminin 60 dakika öncesinde köpeklere 50 mg dozunda oral yolla sildenafil uygulandı. Sperma toplama işlemi parmak maniplasyon yöntemiyle 3 gün arayla 12 kez denendi. Spermanın alınma işleminden sonra, sperma hacim (birinci, ikinci ve üçüncü fraksiyon yönüyle), ejakülasyon zamanı ve spermatolojik özellikler bakımından değerlendirildi. Köpekler 3 hafta dinlendirildikten sonra, sildenafil uygulaması yapılmaksızın sperma toplama işlemi parmak maniplasyon yöntemiyle 3 gün arayla 12 kez denendi. Sildenafil uygulaması, sildenafil uygulanmayan gruba göre spermanın ikinci (sırasıyla, 1.1 ve 0.7 ml) ve üçüncü fraksiyon (sırasıyla 11 ve 6 ml) hacmine önemli oranda katkıda bulundu ve total ejakülasyon zamanını artırdı (sırasıyla, 11.8 ve 7 dakika, P0.05). Sonuç olarak, sidenafil penis ereksiyonu ve başarıyla spermanın toplanmasında parmak maniplasyon işleminde problem yaşayan köpeklerde kullanılabilir.
In this study, the effects of sildenafil administration on penile erection and semen volume and characteristics in Kangal dogs were studied. A total of 5 Kangal dogs, aging 3-6 years, and with a known fertility were used. In each application, sildenafil was administered orally at a dosage of 50 mg, 60 minutes prior to semen collection. Semen was collected 12 times at 3-day intervals by digital manipulation. After collected, semen was examined for volume (first, second, and third fractions), ejaculation time, and spermatological characteristics. Dogs were rested for 3 weeks after the last semen collection. Following the rest period, semen collection was experienced 12 times at 3-day intervals by digital manipulation without sildenafil application. Sildenafil administration enhanced the volume of the second and third fractions, compared to the non-sildenafil group (1.1 ml versus 0.7 ml and 11 ml versus 6 ml, respectively, P<0.05), and increased the total ejaculation time (11.8 minutes versus 7 minutes, P<0.05). On the other hand, there were no significant differences between the sildenafil and non-sildenafil groups for spermatological characteristics (P>0.05). As a conclusion, sildenafil could be used in dogs, having problems in response to digital manipulation, for penile erection and successful semen collection.
___
1. Anderson KE, Wagner G: Physiology of penile erection. Physiol Rev, 75, 191-236, 1995.
2. Burnett AL: Nitric oxide in the penis: Physiology and pathology. J Urol, 157, 320, 1997.
3. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukoto JM, RAJFER J: Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun, 170, 843-850, 1990.
4. Boolell M, Allen MJ, Ballard SA, Gepi AS, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C: Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile disfunction. Int J Impot Res, 8, 47-52, 1996.
5. Carter AJ, Ballard SA, Naylor AM: Effect of selective phosphodiesterase type 5 inhibitor sildenafil on erectile dysfunction in the anesthetized dog. J Urol, 160, 242-246, 1998.
6. Stief CG, Uckert S, Becker AJ, Truss MC, Jonas U: The effect of specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J Urol, 159, 1390-1393, 1998.
7. Rosen RS, McKenna KE: PDE-5 inhibition and sexual response: Pharmacological mechanism and clinical outcomes. Annu Rev Sex Res, 13, 36-88, 2002
8. Mcauley IW, Kim NN, Min K, Goldstein I, Traish AM: Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway. J Androl, 22, 623628, 2001.
9. Padma-Nathan H, Stecher VJ, Sweeney M, Orazem J, Tseng LJ Deriesthal H: Minimal time to successful intercourse after sildenafil citrate: Results of a randomized, double-blind placebo-controlled trial. Urology, 62, 400-403, 2003.
10. Bucak MN, Tekin N: Protective effect of taurine, glutathione and trehalose on the liquid storage of ram semen. Small Rumin Res, 73, 103-108, 2007.
11. Evans G, Maxwell WMC: Handling and Examination Semen. In, Maxwell WMC (Ed): Salamon’s Artificial Insemination of Sheep and Goat. Sydney, Butterworths, 93106, 1987.
12. Schafer S, Holzmann A: The use of transmigration and spermac stain to evaluate epididymal cat spermatozoa. Anim Reprod Sci, 59, 201-211, 2000.
13. Ueno N, Iwamoto Y, Segawa N, Kinoshita M, Ueda H, Katsuoka Y: The effect of sildenafil on electrostimulationinduced erection in the rat model. Int J Impot Res, 14, 251255, 2002.
14. Taher A, Browo P, Kaml ST, Shahab N: Relaxation effect of nitric oxide-donor on diabetic penile smooth muscle in vitro. Clin Hemorheol Microcirc, 23, 277-281, 2000.
15. Tekin N, İzgür H, Özyurt M: Semen collection with the aid of penis massage and investigations on the basic spermatological traits in the dogs. Selcuk Univ J Vet Fac, 3, 83-95, 1997.
16. Akçay E: Andrological examinations and semen cryopreservation in Kangal Sheepdogs. PhD thesis (In Turkish), Ankara University Health Sciences Institute, 2000.
17. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA: Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med, 338, 1397-1404, 1998.
18. Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH: Clinical safety of oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction. Int J Impot Res, 10, 69-73, 1998.
19. Çoyan K, Kaya A: Der Einfluss von Sildenafil (Viagra) auf das Geschlechtsverhalten von Schafböcken, Wien Tierarztl Mschr, 92, 30-33. 2005.
20. Purvis K, Muirhead GJ, Harness JA: The effects of sildenafil on human sperm function in healthy volunteers. Br J Clin Pharmacol, 53, 53-60, 2002
21. Plessis DS, Jongh DP, Franken DR: Effect of acute in vivo sildenafil citrate and in vitro 8-bromo-cGMP treatments on semen parameters and sperm function. Fertil Steril, 81, 10261033, 2004.